# Neuroute

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuroute

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.neuroute.co
- Total disclosed funding: $1M
- Latest round: Seed (Jan 31, 2022)
- Investors on record: 1

## About

Based in the UK and founded in 2019, Neuroute Limited, formerly known as Neucruit, operates as a provider of healthcare technology used by teams in biotech, medtech, and pharma and counts Motto, Modus TX, and Flow among its customers to test for patient feasibility, market research, and patient recruitment. In February 2022, Neuroute Limited raised pre-seed funding from investor Nina Capital.

The company offers a healthcare platform that helps healthcare companies with the development of clinical products by easy targeting of their patients. The company uses artificial intelligence-based technology to streamline clinical trial design, planning, and recruitment. The company's platform provides data on hospital sites, disease areas, and patient-reported outcomes to generate insights for reducing timelines.

The company plans to use the February 2022 funding to research and develop its clinical trials.

## Funding rounds

- Seed, Jan 31, 2022, $1M — Nina Capital

## Investors

- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Seed